Uchimoto, Taizo
Matsuda, Takuya
Komura, Kazumasa
Fukuokaya, Wataru
Adachi, Takahiro
Hirasawa, Yosuke
Hashimoto, Takeshi
Yoshizawa, Atsuhiko
Saruta, Masanobu
Hashimoto, Mamoru
Higashio, Takuya
Tsuchida, Shuya
Nishimura, Kazuki
Tsujino, Takuya
Nakamura, Ko
Fukushima, Tatsuo
Nishio, Kyosuke
Yamamoto, Shutaro
Iwatani, Kosuke
Urabe, Fumihiko
Mori, Keiichiro
Yanagisawa, Takafumi
Tsuduki, Shunsuke
Takahara, Kiyoshi
Inamoto, Teruo
Miki, Jun
Fujita, Kazutoshi
Kimura, Takahiro
Ohno, Yoshio
Shiroki, Ryoichi
Uemura, Hirotsugu
Azuma, Haruhito
Funding for this research was provided by:
Japan Society for the Promotion of Science (21H03070)
Kenzo Suzuki Foundation
SGH Foundation
Naito Foundation
Cancer Translational Research Foundation of Japanese Urological Association
Article History
Accepted: 6 May 2024
First Online: 28 May 2024
Declarations
:
: Kazumasa Komura was partially supported by Grant-in-Aid No. 21H03070 (Japan Society for the Promotion of Science), the Kenzo Suzuki Memorial Foundation, the SGH Foundation, the Naito Memorial Foundation, and the Cancer Translational Research Foundation of Japanese Urological Association.
: Taizo Uchimoto, Takuya Matsuda, Kazumasa Komura, Wataru Fukuokaya, Takahiro Adachi, Yosuke Hirasawa, Takeshi Hashimoto, Atsuhiko Yoshizawa, Masanobu Saruta, Mamoru Hashimoto, Takuya Higashio, Shuya Tsuchida, Kazuki Nishimura, Takuya Tsujino, Ko Nakamura, Tatsuo Fukushima, Kyosuke Nishio, Shutaro Yamamoto, Kosuke Iwatani, Fumihiko Urabe, Keiichiro Mori, Takafumi Yanagisawa, Shunsuke Tsuduki, Kiyoshi Takahara, Teruo Inamoto, Jun Miki, Kazutoshi Fujita, Takahiro Kimura, Yoshio Ohno, Ryoichi Shiroki, Hirotsugu Uemura, and Haruhito Azuma have no conflicts of interest that are directly relevant to the content of this article.
: This study was approved by the Institutional Review Board of Osaka Medical and Pharmaceutical University (approval number: RIN-750-2571, approved on 24 January, 2020). This observational study adhered to ethical principles aligned with the Declaration of Helsinki, the International Conference on Harmonisation’s Good Clinical Practice guidelines, Good Pharmacoepidemiology Practices, and relevant laws for non-interventional and observational studies.
: All patients provided written informed consent prior to data collection for the study.
: Not applicable.
: The data from this study can be accessed by academic and commercial partners upon a reasonable request, subject to institutional review board approval and a data use agreement. For further details or to reanalyze the study’s data, contact the Lead Contact at kazumasa.komura@ompu.ac.jp.
: Not applicable.
: TU: conceptualization, data curation, analysis, investigation, methodology, software, visualization, writing original draft, supervision. TM: data curation, analysis, investigation, methodology, software, visualization. KK: data curation, investigation, investigation, writing the original draft, supervision. WF: investigation, data curation, validation. AA: validation, methodology. YH: methodology, validation. TH: methodology, validation. AY: data curation. MS: data curation. MH: analysis. TH: data curation, analysis. ST: investigation. KN: data curation. TT: methodology, data curation. KN: investigation. TF: data curation, analysis. KN: validation. SY: data curation. KI: investigation, supervision. FU: investigation, validation, supervision. KM: methodology, data analysis. TY: investigation. ST: writing original draft, review. KT: editing, supervision. TI: data curation. JM: data curation, analysis. KF: review and editing, supervision. TK: investigation, validation, supervision. YO: supervision. RS: supervision. HU: supervision. HA: supervision.